Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 160

    1.

    A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice.

    Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L.

    Diabetes. 2002 May;51(5):1367-74.PMID: 11978632 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.

    Trembleau S, Penna G, Gregori S, Chapman HD, Serreze DV, Magram J, Adorini L.

    J Immunol. 1999 Sep 1;163(5):2960-8.PMID: 10453045 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.

    Trembleau S, Penna G, Gregori S, Magistrelli G, Isacchi A, Adorini L.

    J Immunol. 2000 Dec 15;165(12):6748-55.PMID: 11120794 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases.

    Adorini L, Penna G, Giarratana N, Uskokovic M.

    J Cell Biochem. 2003 Feb 1;88(2):227-33. Review.PMID: 12520519 [PubMed - indexed for MEDLINE]Related articles

    6.

    Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes.

    Adorini L.

    Ann N Y Acad Sci. 2003 Apr;987:258-61. Review.PMID: 12727648 [PubMed - indexed for MEDLINE]Related articles

    7.

    CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.

    Mukherjee R, Chaturvedi P, Qin HY, Singh B.

    J Autoimmun. 2003 Nov;21(3):221-37.PMID: 14599847 [PubMed - indexed for MEDLINE]Related articles

    8.

    Human chorionic gonadotropin is an immune modulator and can prevent autoimmune diabetes in NOD mice.

    Khil LY, Jun HS, Kwon H, Yoo JK, Kim S, Notkins AL, Yoon JW.

    Diabetologia. 2007 Oct;50(10):2147-55. Epub 2007 Aug 4.PMID: 17676307 [PubMed - indexed for MEDLINE]Related articles

    9.

    Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes.

    Trembleau S, Penna G, Gregori S, Gately MK, Adorini L.

    Eur J Immunol. 1997 Sep;27(9):2330-9.PMID: 9341777 [PubMed - indexed for MEDLINE]Related articles

    10.

    Molecular mechanisms for gender differences in susceptibility to T cell-mediated autoimmune diabetes in nonobese diabetic mice.

    Bao M, Yang Y, Jun HS, Yoon JW.

    J Immunol. 2002 May 15;168(10):5369-75.PMID: 11994496 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Th1 and Th2 pancreatic inflammation differentially affects homing of islet-reactive CD4 cells in nonobese diabetic mice.

    Hill NJ, Van Gunst K, Sarvetnick N.

    J Immunol. 2003 Feb 15;170(4):1649-58.PMID: 12574327 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.

    Ott PA, Anderson MR, Tary-Lehmann M, Lehmann PV.

    Cell Immunol. 2005 May;235(1):1-11. Epub 2005 Aug 24.PMID: 16122720 [PubMed - indexed for MEDLINE]Related articles

    13.

    Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.

    Gregori S, Giarratana N, Smiroldo S, Adorini L.

    J Immunol. 2003 Oct 15;171(8):4040-7.PMID: 14530324 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.

    Tarbell KV, Yamazaki S, Olson K, Toy P, Steinman RM.

    J Exp Med. 2004 Jun 7;199(11):1467-77.PMID: 15184500 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Absence of significant Th2 response in diabetes-prone non-obese diabetic (NOD) mice.

    Hartemann-Heurtier A, Richard MF, Boitard C.

    Clin Exp Immunol. 1999 May;116(2):225-30. Erratum in: Clin Exp Immunol. 3003 Apr;132(1):180. PMID: 10337011 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo.

    Weber SE, Harbertson J, Godebu E, Mros GA, Padrick RC, Carson BD, Ziegler SF, Bradley LM.

    J Immunol. 2006 Apr 15;176(8):4730-9.PMID: 16585566 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation.

    Serreze DV, Chapman HD, Post CM, Johnson EA, Suarez-Pinzon WL, Rabinovitch A.

    J Immunol. 2001 Jan 15;166(2):1352-9.PMID: 11145720 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Paralytic autoimmune myositis develops in nonobese diabetic mice made Th1 cytokine-deficient by expression of an IFN-gamma receptor beta-chain transgene.

    Serreze DV, Pierce MA, Post CM, Chapman HD, Savage H, Bronson RT, Rothman PB, Cox GA.

    J Immunol. 2003 Mar 1;170(5):2742-9.PMID: 12594305 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.

    Tarbell KV, Petit L, Zuo X, Toy P, Luo X, Mqadmi A, Yang H, Suthanthiran M, Mojsov S, Steinman RM.

    J Exp Med. 2007 Jan 22;204(1):191-201. Epub 2007 Jan 8.PMID: 17210729 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data